Status:

COMPLETED

AIMN Multicenter Study: Staging of Lymphomas Using PET/CT

Lead Sponsor:

IRCCS San Raffaele

Conditions:

Lymphoma

Eligibility:

All Genders

18+ years

Brief Summary

In recent years, the introduction of PET/CT tomographs (which have now almost completely replaced tomographs equipped with PET alone), has allowed a significant increase in diagnostic accuracy in the ...

Eligibility Criteria

Inclusion

  • Established lymphoma (non-Hodgkin's lymphoma and Hodgkin's disease) being staged;
  • Performing the PET/CT examination within two weeks of diagnosis and before treatment;
  • Signing of the Informed Consent.

Exclusion

  • patients \<18 years;
  • Patients who have not signed the Informed Consent;
  • Execution of previous anti-inflammatory or anti-inflammatory therapies in the 4 weeks preceding the PET exam.

Key Trial Info

Start Date :

October 7 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 24 2011

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06179693

Start Date

October 7 2009

End Date

February 24 2011

Last Update

December 22 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Irccs San Raffaele

Milan, Italy

AIMN Multicenter Study: Staging of Lymphomas Using PET/CT | DecenTrialz